Genetically Triggered Thoracic Aortic Disease: Who Should be Tested?

Abstract excerpt

Up to 25% of patients with thoracic aortic disease have an underlying Mendelian pathogenic variant. This is a heterogeneous group of disorders known as heritable thoracic aortic diseases (HTAD). Diagnosing associated pathogenic gene variants and syndromes is critical, as the underlying genetics have an implication in medical management, surveillance, thresholds for surgical intervention, surgical risk, pregnancy...

Topics

Join the communities discussing this publication.

• Aortic aneurysm repair treatments
• Aortic Disease and Treatment Approaches
• Connective tissue disorders research